Results and prospects of development of new polyphenolic drugs for cancer patients

The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products bas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2017-11, Vol.8 (59), p.100951-100956
Hauptverfasser: Anisimov, Vladimir N, Larsen, Stig, Lofberg, Stig, Baldueva, Irina A, Malek, Anastasia V, Nielsen, Tea Kirkegaard, Fedoros, Elena I, Perminova, Irina V, Drobyshev, Evgeny Yu, Bykov, Vladimir N, Panchenko, Andrey V, Scherbakov, Alexander M, Belyaev, Alexey M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.22307